This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Jan D. Bos, MD, PhD; Eddy A. Wierenga, PhD; J. Henk Sillevis Smitt, MD; Frans L. van der Heijden, PhD; Martien L. Kapsenberg, PhD

Arch Dermatol. 1992;128(11):1509-1512.

Abstract
• Background.—
In this review, present knowledge of atopic eczema immunopathogenesis is summarized, emphasizing recent new findings. Systemic abnormalities in cell-mediated immunity have not been demonstrated firmly in patients with atopic eczema. Within the skin itself, there is evidence for decreased cell-mediated immunity, which is partially correlated with the severity of skin disease. Atopic eczema, however, cannot be regarded as a direct result of decreased cutaneous cell-mediated immunity, since immunophenotyping studies have revealed activated T cells as well as dendritic cells within involved skin. In addition, disease marker studies in peripheral blood indicate vigorous T-cell activation in atopic dermatitis.

Observations.—
The original observation of IgE molecules on the membranes of Langerhans cells may indicate trapping of IgE allergen complexes, their processing, and subsequent presentation to allergen-specific T cells within involved skin. Recent findings as to the abnormal regulation of IgE synthesis in atopy point to a preferential expansion of interleukin 4 and interleukin 5 producing allergen-specific T cells, leading to increased production of interleukin 4 and thus increased levels of allergen-specific IgE. We have prepared atopic skin as well as peripheral blood-derived T-cell clones and determined their specificity and cytokine production profile. Results indicate in situ production of interleukin 4 and interleukin 5 within involved skin in response to environmental antigens.

Conclusions.—
These new findings as to the basis of IgE dysregulation in atopy, as well as to the identification of an abnormal cytokine secretion pattern by T cells presumed to be central in immunopathogenesis of atopy-related disorders, suggest a distorted and cytokine-mediated self-perpetuating response of the skin immune system to environmental allergen(s) in the pathogenesis of skin disease in atopy. These observations may have important implications for the development of new therapies for atopic eczema.

(Arch Dermatol. 1992;128:1509-1512)

Author Affiliations
From the Departments of Dermatology (Drs Bos and Sillevis Smitt) and Cell Biology and Histology (Drs Wierenga, van der Heijden, and Kapsenberg), University of Amsterdam, Academisch Medisch Centrum, Amsterdam, the Netherlands.

Footnotes
Accepted for publication March 9, 1992.

Reprint requests to Department of Dermatology, University of Amsterdam, Academisch Medisch Centrum A0-235, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands (Dr Bos).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Transgenic mice which overproduce Th2 cytokines develop spontaneous atopic dermatitis and asthma
Lee and Flavell
Int Immunol 2004;16:1155-1160.
ABSTRACT | FULL TEXT  

Interleukin-10 Therapy--Review of a New Approach
Asadullah et al.
Pharmacol. Rev. 2003;55:241-269.
ABSTRACT | FULL TEXT  

Threshold Signaling of Human Th0 Cells in Activation and Anergy: Modulation of Effector Function by Altered TCR Ligand
Verhoef and Lamb
J. Immunol. 2000;164:6034-6040.
ABSTRACT | FULL TEXT  

The Immunopathogenesis of Cutaneous T-Cell Lymphoma: Abnormal Cytokine Production by Sezary T Cells
Rook et al.
Arch Dermatol 1993;129:486-489.
ABSTRACT